The news that exports to the US will not restart before next year as well as the September quarter performance are sentiment dampeners.
Last month, the US Food and Drugs Administration had placed Wockhardt's facilities in Waluj near Aurangabad on import alert, barring supply of various products from these facilities to the US.
Wockhardt MD Murtaza Khorakiwala said his firm had responded to the FDA's observations but declined to give details.
.jpg)
To focus on molecules at advanced stage of development; move to impact 200 scientists.
Gujarat has around 3,000 licensees for allopathic drug manufacturing, apart from around seven homeopathic licensees, 500 ayuvedic and 600-700 cosmetics licensees
The Indian Pharmaceutical Alliance has approached regulator for a dialogue to understand the concern raised by it
The company has received a communication from the Medicines and Healthcare Products Regulatory Agency, United Kingdom, whereby the agency has decided to withdraw the previously issued GMP Certificate to the company's manufacturing facility situated at Kadaiya, Nani Daman, Wockhardt said in a filing to the Bombay Stock Exchange.
In 2014, Sun Pharma agreed to buy Ranbaxy -- which was then controlled by Daiichi.
This is not just a Ranbaxy or Wockhardt problem, says K Satish Reddy
Bharat Biotech, Serum Institute, Zydus Cadila, Panacea Biotec, Indian Immunologicals, Mynvax and Biological E are among the domestic pharma firms working on the coronavirus vaccines in India.
Of the 30-share Sensex pack, 22 ended with losses while NTPC ended flat at Rs 127.30.
Test reports from UP food regulator started the controversy.
The under-one-minute films are titled 'Menu Cards, Mom and Neighbours'.
The company buys distressed assets across the globe and turns them around to not only add to its books but also its product pipeline and regions.
'The Khalistanis get bulk of the money from abroad.' 'Where did Amritpal's Mercedes come from, which costs well over Rs 60 lakhs?' 'Where does his fleet of vehicles come from?' 'Local Punjabis can certainly not contribute this kind of money.'
Informing about his decision, Maurya said in a tweet in Hindi, 'Due to the attitude of gross neglect towards Dalits, backwards, farmers, unemployed youth and small and medium-sized traders, I am resigning from the council of ministers of Yogi (Adityanath) of UP.'
Roadshows will be held in Singapore, Hong Kong, London, New York and Boston, NTPC gained close to 1%.
Inspections only in domestic authorities' presence, visiting US drug regulator told
The Competition Commission of India and the US Federal Trade Commission are yet to give their nod to the biggest pharma merger and acquisition deal this year in the Asia-Pacific region.
Elizabeth Holmes founded Theranos in 2003 and it promised ground-breaking methods that would allow quick results for a wide range of tests with just one drop of blood.
Pharma was the top losing index amid worries about their earnings outlook with Lupin down over 4%
Patanjali's packet milk to be lower than competitor brands by Rs 2 a litre
'Nobody is attacking the company or the vaccine.' 'The concerns are about the process and the lack of transparency.'
4 Ranbaxy facilities in India have been barred from exporting to US.
According to an official statement, the FDA has determined that the Moderna COVID-19 vaccine has met the statutory criteria for issuance of an emergency use authorisation (EUA).
Its Waluj manufacturing facility in Maharashtra failed to meet the good manufacturing norms prescribed by the UK drug regulator.
South-east Asian countries are emerging as preferable destination for India's pharma companies to expand their business as they share similar patient population and disease profile and moreover, have a conducive environment for their operations like easy market approach without any regulatory uncertainty, the survey of Indian pharma firms highlighted.
'The focus for value creation will be on all business segments.'
The government plans to rationalise trade margins for many other medical devices, besides stents and knee implants.
Vice President Mike Pence said Trump had authorised a ban on entry of foreign nationals who travelled to Iran in the last 14 days. The United States also advised its citizens not to travel to parts of South Korea and Italy, from where reports of coronavirus have appeared.
Researchers claim to have developed a new treatment for ovarian cancer that can increase the rate of tumour shrinkage and prolong the time until cancers recur.
There are a number of vaccine candidates already in clinical trial and a few out of those candidates have completed phase 1/2 status, he said, adding that there are trials that will be going into phase three sometime at the end of July and then others will follow in the months of August, September and October.
Asset valuation consultancy sees brand value slip to $2.2 billion.
The joint entity will have a market share of nine per cent in India. Analysts tracking the company said one of the key outcomes of the merger would be to create a single brand entity of Sun and the Ranbaxy brand would eventually dissolve.
A team at Bristol University used recently developed techniques to validate that the vaccine accurately follows the genetic instructions programmed into it by the Oxford University team.
A look at the top tweets from your favourite Bollywood celebrities.
The S&P BSE Sensex surged 217 points to end at 25,736.
Maggi re-entered the market on November 9.
The ICMR is working on a war footing to develop the testing ecosystem -- especially for the screening blood tests. NIV, Pune, is in the process of validating antibody-based screening kits.
AstraZeneca Plc and the University of Oxford are facing questions about their Covid-19 vaccine and whether regulators would quickly authorise its emergency use after the pharma company acknowledged an error in the vaccine dosage received by some participants and other irregularities and omissions, according to the New York Times.
© 2026 Rediff.com - Investor Information - Advertise with us - Disclaimer - Privacy Policy - Sitemap - Feedback - About us - Terms of use - Grievances